Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $118.7 million.

  • Usana Health Sciences' Total Current Liabilities rose 338.48% to $118.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.7 million, marking a year-over-year increase of 338.48%. This contributed to the annual value of $139.6 million for FY2024, which is 1748.5% up from last year.
  • Latest data reveals that Usana Health Sciences reported Total Current Liabilities of $118.7 million as of Q3 2025, which was up 338.48% from $121.6 million recorded in Q2 2025.
  • Usana Health Sciences' Total Current Liabilities' 5-year high stood at $168.1 million during Q1 2021, with a 5-year trough of $103.9 million in Q2 2024.
  • For the 5-year period, Usana Health Sciences' Total Current Liabilities averaged around $133.8 million, with its median value being $131.9 million (2022).
  • Per our database at Business Quant, Usana Health Sciences' Total Current Liabilities skyrocketed by 2349.41% in 2021 and then tumbled by 2033.25% in 2022.
  • Quarter analysis of 5 years shows Usana Health Sciences' Total Current Liabilities stood at $158.0 million in 2021, then decreased by 8.95% to $143.8 million in 2022, then decreased by 17.37% to $118.8 million in 2023, then increased by 17.48% to $139.6 million in 2024, then dropped by 15.01% to $118.7 million in 2025.
  • Its Total Current Liabilities stands at $118.7 million for Q3 2025, versus $121.6 million for Q2 2025 and $137.4 million for Q1 2025.